Volume 7, Issue 3, May 2019, Page: 60-67
Widening the Field of Indication of Conservative Management of Unruptured Tubal Pregnancy in Low Resources Settings: Lessons Learnt from 10-year Experience in Three University Teaching Hospitals in Yaoundé (Cameroon)
Mve Koh Valere, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
Essiben Felix, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
Essome Henri, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
Dang Atanga Danielle, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
Mbu Enow Robinson, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
Received: Mar. 17, 2019;       Accepted: Apr. 25, 2019;       Published: May 23, 2019
DOI: 10.11648/j.jgo.20190703.11      View  98      Downloads  18
Abstract
Ectopic pregnancy is the leading cause of maternal mortality in the first trimester. When a patient is admitted before rupture, organ-preserving management which keeps a higher fertility rate than ablative surgery can be done. The incidence of Unruptured Ectopic Pregnancy (UTP) on admission is unknown. In the study facilities, methotrexate treatment was given to most of UTP regardless of Fernandez score. The aim of this study was therefore to assess the lessons learnt from that experience. Methods: It was a cross sectional study over a 10 years period, conducted in four university teaching hospitals affiliated to the University of Yaoundé I, Cameroon. Included patients were managed either by therapeutic abstention, single or multidose intra muscular MTX. Onset of clinical acute abdomen was the only indication of failure of conservative management and prompted emergency laparotomy. Results: We included 153 UTP cases. The incidence of UTP on admission was 0.46%, the mean age 28.4 ± 4.9, 88.2% were admitted at a gestational age <9 weeks, 19% had no pelvic pain. Medical treatment by MTX success rate was 81.7% but was not related to mono or multiple-dose (p=0.87), the success rate when β-hCG value was ≥ 10000 mIU/ml was 63.3% (p=0.004). When Fernandez score was ≥ 13, 21/25 (84%) were still successful including 3/7 with cardiac activity. (p=0.007). Conclusions: The incidence of UTP on admission is approximately 1/10th of all EP. Some UTP patients should be given MTX treatment opportunity even when Fernandez score recommends surgical management.
Keywords
Unruptured Ectopic Pregnancy, Widen Indication, Acute Abdomen
To cite this article
Mve Koh Valere, Essiben Felix, Essome Henri, Dang Atanga Danielle, Mbu Enow Robinson, Widening the Field of Indication of Conservative Management of Unruptured Tubal Pregnancy in Low Resources Settings: Lessons Learnt from 10-year Experience in Three University Teaching Hospitals in Yaoundé (Cameroon), Journal of Gynecology and Obstetrics. Vol. 7, No. 3, 2019, pp. 60-67. doi: 10.11648/j.jgo.20190703.11
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Tindall VR. Ectopic pregnancy. In: Jeffcoate’s Principles of Gynaecology, 7th edition, Oxford, Butterworth-heinemann Ltd.; 1996: 212-225.
[2]
Cunningham, Mac Donald, Grant, Levena, Gilstrap. Ectopic pregnancy. William Obstetrics 19th edition. USA: Applengton & Hance; 1993. p. 691-715.
[3]
Sara HG, Uzelac PS. Early pregnancy risks. In: DeCherney AH, Nathan L, Goodwin MT, Laufer N, editors. Current Diagnosis and Treatment: Obstetrics and Gynecology. 10th ed. Columbus (OH): McGraw-Hill; 2007: 259–272.
[4]
Thonneau P, Hijazi Y, Goyaux N, Calvez T and Keita N. Ectopic pregnancy in Conakry, Guinea. Bull World Health Organ. 2002; 80: 365-70.
[5]
Saucedo M, Deneux-Tharaux C et Bouvier-Colle MH. Épidémiologie des morts maternelles en France 2001-2006. BEH 2-3, 19 janvier 2010: 10-14.
[6]
Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ and Callaghan WM. Trends in ectopic pregnancy mortality in the United States, 1980–2007. Obstet Gynecol. 2011; 117: 837–43.
[7]
Tebeu PM, Halle Ekane G, Da Itambi, Mbu Enow R, Mawanba Y and Fomulu NJ: Maternal mortality in Cameroon: A university hospital report. Pan African Medical Journal, 2015, 21: 16. doi: 10.11604/pamj.2015.21.16.3912.
[8]
Bhattacharya S, McLernon DJ, Lee AJ and Bhattacharya S. Reproductive Outcomes Following Ectopic Pregnancy: Register-Based Retrospective Cohort Study. PLoS Med. 2012; 9 (6): e1001243.
[9]
Chen XL, Chen ZR, Cao ZL, Han K, Tong YW, Xiang XH et al. The 100 most cited articles in ectopic pregnancy: a bibliometric analysis. SpringerPlus. 2016; 5: 1815. DOI 10.1186/s40064-016-3503-8.
[10]
Panti A, Ikechukwu NE, lukman OO, Yakubu A, Egondu SC and Tanko BA. Ectopic pregnancy at Usmanu Danfodiyo University Teaching Hospital, Sokoto: a ten-year review. Ann Niger Med. 2012; 6 (2): 87–91.
[11]
Lansac Lecomte Maret. Gynécologie pour le praticien. 7e ed. Paris: Masson 2007. 161-163.
[12]
Taran F-A, Kagan K-O, Hübner M, Hoopmann M, Wallwiener D and Brucker S. The Diagnosis and Treatment of Ectopic Pregnancy. Dtsch Arztebl Int. 2015; 112: 693–704.
[13]
Grau EM, Checa Vizca ´ ıno, ´MA, Oliveira M, Lleberia Juanos J, Collado RC, and Yolanda Canet Estevez Y. The Value of Hysterosalpingography following Medical Treatment with Methotrexate for Ectopic Pregnancy. Obstetrics and Gynecology International. Vol 2011, 5 pages. doi: 10.1155/2011/547946.
[14]
Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA et al. Pregnancy-related mortality surveillance United States, 1991-1999. MMWR SurveillSumm 2003; 52: 1-8.
[15]
Farquhar CM. Ectopic pregnancy. Lancet. 2005; 366 (9485): 583-91.
[16]
Foumane P, Mboudou ET, Mbakop Ndingue S, Dohbit JS, Belinga E and Doh A. S. La place du traitement peu ou non invasif dans la prise en charge de la grossesse extra-utérine à l’hôpital gynéco-obstétrique et pédiatrique de Yaoundé: Une analyse rétrospective sur cinq ans. Clin Mother Child Health. 2010; Vol 7, N° 1: 1201–1204.
[17]
Osaheni L Lawani, Okechukwu B Anozie and Ezeonu PO. Ectopic pregnancy: a life-threatening gynecological emergency. International Journal of Women’s Health. 2013; 5: 515–521.
[18]
Mve Koh V, Belinga E, Engbang Ndamba JP and Kasia JM. Macrosomic Newborn Anthropometric Parameters and the Mode of Delivery. Gynecol Obstet (Sunnyvale) 2018, 8: 10.
[19]
Gervaise A, Fernandez H. Le méthotrexate dans le traitement médical des grossesses extra-utérine non rompues. Etude prospective: injection intra-musculaire versus injection in situ sous contrôle échographique. J Gynecol Obstet Biol Reprod 2003; 32: 420-425.
[20]
Shaamash AH, Alshahrani MS, Awadalla NJ and Hakami HW. Falling in serum β human chorionic gonadotropin levels between days 1 and 7 as a new protocol to predict successful single-dose of methotrexate therapy for ectopic pregnancy. Middle East Fertility Society Journal. 2015; 20: 159–164.
[21]
Thia E W H, Loi K, Wang J J and Siow A. Methotrexate treatment for ectopic pregnancy at the KK Women's and Children's Hospital, Singapore. Singapore Med J. 2009; 50 (11): 1058-61.
[22]
Sendy F, AlShehri E, Alajmi A, Bamanie E, Appani S and Taghreed Shams. Failure Rate of Single Dose Methotrexate in Managment of Ectopic Pregnancy. Obstetrics and Gynecology International; Vol 2015, Article 5 pages. http://dx.doi.org/10.1155/2015/902426 Accessed December 10, 2018.
[23]
Lipscomb GH, Givens VM, Meyer NL, Bran D, and Zinberg S. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol. 2005; vol. 192, no. 6, pp. 1844–1847.
[24]
Skubisz M, Dutton P, Duncan WC, Horne AW and Tong S. Using a decline in serum hCG between days 0–4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy and Childbirth. 2013; vol. 13 (1): 30 Doi: 10.1186/1471-2393-13-30.
[25]
Mergenthal MC, Senapati S, Zee J, Taylor LA, Whittaker PG, Takacs P et al. Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes. Am J Obstet Gynecol. 2016; 215: 590. e1-5.
[26]
Guvendag Guven ES, Dilbaz S and Dilbaz B. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study. Acta Obstet Gynecol Scand. 2010; 89: 889–895.
[27]
Yang C, Cai J, Yuhong Geng YH and Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reprod. Biomed. Online. 2017; 383-391.
[28]
Inal ZO and Inal HA. Comparison of Four Methods of Treating Ectopic Pregnancy: A Retrospective Cohort Study. Geburtshilfe Frauenheilkd. 2018 Jan; 78 (1): 70–77.
[29]
Yıldırım A, Cırık DA, Altay M and Gelison Q. Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen. Arch Gynecol Obstet. 2015; 291 (6): 1327–1332.
[30]
Barnhart K, Mennuti MT, Benjamin I, Jacobson S, Goodman D and Coutifaris C. Prompt diagnosis of ectopic pregnancy in an emergency department setting. Obstet Gynecol. 1994 Dec; 84 (6): 1010-5.
[31]
Saxon D, Falcone T, Mascha EJ, Marino T, Yao M and Tulandi TA. Study of ruptured tubal ectopic pregnancy. Obstet Gynecol. 1997 Jul; 90 (1): 46-9.
[32]
Shaamash AH, Alshahrani MS, Awadalla NJ and Hakami HW. Falling in serum β human chorionic gonadotropin levels between days 1 and 7 as a new protocol to predict successful single-dose of methotrexate therapy for ectopic pregnancy. Middle East Fertility Society Journal. 2015; 20: 159–164.
[33]
Pooja Rajesh Vaswani. Predictors of Success of Medical Management of Ectopic Pregnancy in a Tertiary Care Hospital in United Arab Emirates. Journal of Clinical and Diagnostic Research. 2014; Aug, Vol-8 (8): OC04-OC08.
[34]
Bonin L, Pedreiro C, Moret S, Chene G, Gaucherand P and Lamblin G. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases. Eur J Obstet Gynecol Reprod Biol. Jan 2017; Vol 208: 23–30.
[35]
Ubung Iklaki C, Ife Emechebe C, Charles Obinna Njoku C and Ago B. Review of Ectopic Pregnancy as a Cause of Maternal Morbidity and Mortality in a Developing Country. IOSR-Journal of Dental and Medical Sciences (IOSR-JDMS). 2015; Vol 14; 8 Ver. VI Aug: 86-91.
[36]
Schneider J, Berger CJ and Cattell C. Maternal mortality due to ectopic pregnancy. A review of 102 deaths. Obstet Gynecol. 1977 May; 49 (5): 557-61.
Browse journals by subject